NanoenTekInc
NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a resid… Read more
NanoenTekInc (039860) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.031x
Based on the latest financial reports, NanoenTekInc (039860) has a cash flow conversion efficiency ratio of 0.031x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.26 Billion) by net assets (₩73.19 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NanoenTekInc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how NanoenTekInc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
NanoenTekInc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NanoenTekInc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nexen Corporation
KO:005720
|
0.031x |
|
TOLUF
OTCQX:TOLUF
|
N/A |
|
Daihan Pharmaceutical Co.Ltd
KQ:023910
|
0.032x |
|
FFD Financial Corp
PINK:FFDF
|
N/A |
|
Dusit Thani Public Company Limited
BK:DUSIT
|
0.122x |
|
Kenilworth Systems C
PINK:KENS
|
2.767x |
|
Alpha Cognition Inc
NASDAQ:ACOG
|
-0.158x |
|
Cardiol Therapeutics Inc Class A
NASDAQ:CRDL
|
-0.724x |
Annual Cash Flow Conversion Efficiency for NanoenTekInc (2013–2024)
The table below shows the annual cash flow conversion efficiency of NanoenTekInc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩73.99 Billion | ₩-2.46 Billion | -0.033x | -175.79% |
| 2023-12-31 | ₩53.59 Billion | ₩-645.79 Million | -0.012x | -108.64% |
| 2022-12-31 | ₩57.65 Billion | ₩8.04 Billion | 0.140x | -21.38% |
| 2021-12-31 | ₩52.34 Billion | ₩9.29 Billion | 0.177x | +41.71% |
| 2020-12-31 | ₩45.49 Billion | ₩5.70 Billion | 0.125x | +25.86% |
| 2019-12-31 | ₩41.03 Billion | ₩4.08 Billion | 0.100x | +131.90% |
| 2018-12-31 | ₩35.15 Billion | ₩1.51 Billion | 0.043x | -40.33% |
| 2017-12-31 | ₩23.73 Billion | ₩1.71 Billion | 0.072x | +160.86% |
| 2016-12-31 | ₩25.58 Billion | ₩-3.02 Billion | -0.118x | -28.30% |
| 2015-12-31 | ₩38.41 Billion | ₩-3.54 Billion | -0.092x | -100.69% |
| 2014-12-31 | ₩35.50 Billion | ₩-1.63 Billion | -0.046x | -152.33% |
| 2013-12-31 | ₩23.58 Billion | ₩2.07 Billion | 0.088x | -- |